Rochester Clinical Research is currently enrolling generally healthy individuals between the ages of 18-49 years old for a vaccine research study. The study will assess the safety and tolerability of two different dosage levels of study vaccine that may protect against a greater number of strains of pneumococcal disease. The study will last approximately 6 months with two visits to our office (within the first 30 days) and 3 telephone calls. Compensation may be available for time and travel up to $225, for those who qualify.
View Trial Details